CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

EarningsnegativeNegative
AI Analysis

Summary

Moderna reported Q2 earnings that met expectations, but the stock declined following news of a setback with its norovirus vaccine program.

Outcome Details

Norovirus vaccine setback

Importance:6/10
Sentiment:
-0.60
earningsvaccinenorovirusclinical_setback
Related Companies

Read the original article

Published by yahoo_finance on July 31, 2026 6:04 PM

Read Original